Mark J Gergen - Net Worth and Insider Trading
Mark J Gergen Net Worth
The estimated net worth of Mark J Gergen is at least $337,408 dollars as of 2024-09-20. Mark J Gergen is the Executive VP, COO of Mirati Therapeutics Inc and owns about 5,748 shares of Mirati Therapeutics Inc (MRTX) stock worth over $337,408. Details can be seen in Mark J Gergen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Gergen has not made any transactions after 2016-01-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J Gergen
Mark J Gergen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Gergen owns 3 companies in total, including Poseida Therapeutics Inc (PSTX) , Halozyme Therapeutics Inc (HALO) , and Mirati Therapeutics Inc (MRTX) .
Click here to see the complete history of Mark J Gergen’s form 4 insider trades.
Insider Ownership Summary of Mark J Gergen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2020-07-09 | director & President and CBO |
| HALO | Halozyme Therapeutics Inc | 2016-09-01 | SVP & Chief Operating Officer |
| MRTX | Mirati Therapeutics Inc | 2016-01-15 | Executive VP & COO |
Mark J Gergen Latest Holdings Summary
Mark J Gergen currently owns a total of 1 stock. Mark J Gergen owns 5,748 shares of Mirati Therapeutics Inc (MRTX) as of January 15, 2016, with a value of $337,408.
Latest Holdings of Mark J Gergen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2016-01-15 | 5,748 | 58.70 | 337,408 |
Holding Weightings of Mark J Gergen
Mark J Gergen Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Gergen has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 10,000 shares on January 15, 2016, which brought Mark J Gergen around $259,200.
Insider Trading History of Mark J Gergen
- 1
Mark J Gergen Trading Performance
Mark J Gergen Ownership Network
Mark J Gergen Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
Mark J Gergen is the director & President and CBO of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
Mark J Gergen Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Gergen. You might contact Mark J Gergen via mailing address: C/o Mirati Therapeutics Inc., 9393 Town Centre Drive, Ste 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
